Cancer Patient Equity Act of 2021
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Sep 27, 2021)
Cancer Patient Equity Act of 2021
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
What just happenedSep 28, 2021
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseSep 27, 2021
- Sep 28, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 27, 2021Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Sep 27, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Sep 27, 2021IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Sep 27, 2021IntroReferralIntro-H
Introduced in House
- Sep 27, 2021IntroReferral1000
Introduced in House